Enzo
Enzo Biochem Fiscal Q3 Revenues Fall 20 Percent; Firm Examining Strategic Alternatives
Enzo has engaged investment bank Jefferies to evaluate strategic alternatives for the company and its various divisions and assets.
New York State Approves Enzo Biochem HPV Molecular Test
Enzo expects to make several announcements related to other molecular laboratory-developed tests this year and provide a timeline for US FDA submissions.
Enzo Biochem Fiscal Q2 Revenues Rise 8 Percent
The company attributed the revenue increase to higher sales in its life science segment and ongoing COVID-19 testing revenues.
Enzo Biochem Q1 2022 Revenues Down 8 Percent
The company said its life sciences revenues fell 9 percent from Q1 2021 because of ongoing COVID-19-related shutdowns in Europe, among other reasons.
Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel
Through the partnership, travelers can now schedule COVID-19 diagnostic testing at Enzo locations using CLX Health's TrustAssure platform.
Mar 15, 2021
Enzo Biochem Q2 Revenues Up 62 Percent
Dec 9, 2020
Enzo Biochem Q1 Revenues Up 42 Percent
Oct 13, 2020
Enzo Biochem Q4 Revenues Down 7 Percent
Jun 8, 2020
Enzo Biochem Q3 Revenues Down 14 Percent
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Oct 15, 2019